NL7113670A - - Google Patents

Info

Publication number
NL7113670A
NL7113670A NL7113670A NL7113670A NL7113670A NL 7113670 A NL7113670 A NL 7113670A NL 7113670 A NL7113670 A NL 7113670A NL 7113670 A NL7113670 A NL 7113670A NL 7113670 A NL7113670 A NL 7113670A
Authority
NL
Netherlands
Application number
NL7113670A
Other versions
NL168511C (nl
NL168511B (nl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7113670A publication Critical patent/NL7113670A/xx
Publication of NL168511B publication Critical patent/NL168511B/xx
Application granted granted Critical
Publication of NL168511C publication Critical patent/NL168511C/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/30—Halogen atoms or nitro radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom
    • C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56—One oxygen atom and one sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D333/70—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NLAANVRAGE7113670,A 1970-10-05 1971-10-05 Werkwijze voor het bereiden of vervaardigen van een geneesmiddel met een bronchodilatore en/of aggregatie van bloedplaatjes remmende werking en werkwijze voor het bereiden van geneeskrachtige 6-arylpyrimidineverbindingen, geschikt voor gebruik bij de eerst genoemde werkwijze. NL168511C (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7821670A 1970-10-05 1970-10-05

Publications (3)

Publication Number Publication Date
NL7113670A true NL7113670A (fr) 1972-04-07
NL168511B NL168511B (nl) 1981-11-16
NL168511C NL168511C (nl) 1982-04-16

Family

ID=22142671

Family Applications (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE7113670,A NL168511C (nl) 1970-10-05 1971-10-05 Werkwijze voor het bereiden of vervaardigen van een geneesmiddel met een bronchodilatore en/of aggregatie van bloedplaatjes remmende werking en werkwijze voor het bereiden van geneeskrachtige 6-arylpyrimidineverbindingen, geschikt voor gebruik bij de eerst genoemde werkwijze.

Country Status (16)

Country Link
US (1) US3707560A (fr)
JP (2) JPS5648511B1 (fr)
AT (4) AT315856B (fr)
AU (1) AU465734B2 (fr)
BE (1) BE773484A (fr)
CA (1) CA988519A (fr)
CH (4) CH554875A (fr)
DE (2) DE2149249C3 (fr)
DK (1) DK131858C (fr)
ES (4) ES395676A1 (fr)
FI (1) FI55502C (fr)
FR (1) FR2110227B1 (fr)
GB (2) GB1373535A (fr)
NL (1) NL168511C (fr)
SE (2) SE385885B (fr)
ZA (1) ZA716615B (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3908012A (en) * 1970-10-05 1975-09-23 Pfizer Arylpyrimidines-inhibitors of platelet aggregation and bronchodilators
US3895112A (en) * 1970-10-05 1975-07-15 Pfizer Arylpyrimidines in the relaxation of smooth muscle
US3859288A (en) * 1970-10-05 1975-01-07 Pfizer Arylpyrimidines - inhibitors of platelet aggregation and bronchodilators
US3835132A (en) * 1972-02-01 1974-09-10 Shell Oil Co Morpholino-piperazinyl pyrimidines
US3950525A (en) * 1973-06-19 1976-04-13 Pfizer Inc. Relaxation of smooth muscle in a mammal
DE2343419A1 (de) * 1973-08-29 1975-03-13 Gruenenthal Chemie Verfahren zur herstellung von pyrimidinderivaten
US4725600A (en) * 1984-07-13 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Pyrimidine compounds having activity as a cardiotonic anti-hypertensive cerebrovascular vasodilator and anti-platelet aggregation agent
US4935516A (en) * 1988-01-29 1990-06-19 Ube Industries, Ltd. Process for preparing 4-hydroxypyrimidine
JPH0625157B2 (ja) * 1988-01-29 1994-04-06 宇部興産株式会社 4―ヒドロキシピリミジン類の製造方法
DE3825647A1 (de) * 1988-07-28 1990-02-01 Geyer Gmbh & Co Christian Vorrichtung zur befestigung eines elektrischen schaltgeraetes
DE3905364A1 (de) * 1989-02-22 1990-08-23 Hoechst Ag Substituierte pyrimidin-derivate, verfahren zu ihrer herstellung und ihre verwendung als tool
ATE250053T1 (de) * 1999-07-15 2003-10-15 Pharmacopeia Inc Bradikinin b1 rezeptor antagonisten
AU2003214110A1 (en) * 2002-03-15 2003-09-29 Ciba Specialty Chemicals Holding Inc. 4-aminopyrimidines and their use for the antimicrobial treatment of surfaces
JP2005531574A (ja) * 2002-05-22 2005-10-20 アムジエン・インコーポレーテツド 痛みの治療にバニロイド受容体リガンドとして使用するためのアミノ−ピリジン、−ピリジンおよびピリダジン誘導体
JP2006521345A (ja) * 2003-03-28 2006-09-21 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー ニコチン性アセチルコリン受容体の正のアロステリック調節剤
US20060235036A1 (en) * 2005-04-15 2006-10-19 Doherty Elizabeth M Vanilloid receptor ligands and their use in treatments
JP2009164373A (ja) * 2008-01-08 2009-07-23 Toshiba Corp 半導体装置
NZ601547A (en) * 2010-01-25 2014-04-30 Chdi Foundation Inc Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
WO2013033068A1 (fr) 2011-08-30 2013-03-07 Stephen Martin Courtney Inhibiteurs de kynurénine-3-monooxygénase, compositions pharmaceutiques et procédés d'utilisation de ces compositions
SG2014012926A (en) 2011-08-30 2014-06-27 Chdi Foundation Inc Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
MX372995B (es) 2014-07-17 2020-04-13 Chdi Foundation Inc Metodos y composiciones para el tratamiento de trastornos relacionados con vih.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3047462A (en) * 1959-03-06 1962-07-31 Lab Jacques Logeais Soc D Expl Quinazolone anti-inflammatory composition

Also Published As

Publication number Publication date
SE7410488L (fr) 1974-08-16
DE2165962C2 (de) 1982-05-13
CH554876A (fr) 1974-10-15
GB1373535A (en) 1974-11-13
ES395676A1 (es) 1974-10-16
JPS578107B2 (fr) 1982-02-15
ES420211A1 (es) 1976-03-16
SE390304B (sv) 1976-12-13
ZA716615B (en) 1972-06-28
SE385885B (sv) 1976-07-26
DE2149249C3 (de) 1975-07-03
FI55502B (fi) 1979-04-30
ES420210A1 (es) 1976-06-01
JPS5636468A (en) 1981-04-09
US3707560A (en) 1972-12-26
CH554875A (fr) 1974-10-15
CH554346A (fr) 1974-09-30
JPS5648511B1 (fr) 1981-11-16
AT315856B (de) 1974-05-15
GB1373536A (en) 1974-11-13
ES420209A1 (es) 1976-06-01
AU3425971A (en) 1973-04-12
AT317229B (de) 1974-08-26
CA988519A (en) 1976-05-04
AU465734B2 (en) 1975-10-09
FR2110227B1 (fr) 1975-02-07
FI55502C (fi) 1979-08-10
AT316563B (de) 1974-06-15
NL168511C (nl) 1982-04-16
CH542218A (fr) 1973-11-15
DK131858B (da) 1975-09-15
DE2149249B2 (de) 1974-11-07
AT314540B (de) 1974-04-10
DE2149249A1 (de) 1972-04-13
BE773484A (fr) 1972-04-05
DK131858C (da) 1976-02-16
FR2110227A1 (fr) 1972-06-02
DE2165962A1 (de) 1972-08-31
NL168511B (nl) 1981-11-16

Similar Documents

Publication Publication Date Title
FR2090862A5 (fr)
HU163983B (fr)
FR2117532A5 (fr)
JPS578107B2 (fr)
FR2086416A1 (fr)
FR2090966A5 (fr)
FR2096902B1 (fr)
FR2116142A5 (fr)
JPS47113U (fr)
FR2076134B1 (fr)
FR2085139A5 (fr)
FR2097294A5 (fr)
FR2085675A1 (fr)
FI53208C (fr)
FR2085360A1 (fr)
FR2076155B1 (fr)
FR2085215B1 (fr)
FR2086453B1 (fr)
FR2076143B1 (fr)
HU167071B (fr)
FR2116008A5 (fr)
DE2116208C3 (fr)
FR2085181B1 (fr)
FR2101160A1 (fr)
FR2085230B1 (fr)

Legal Events

Date Code Title Description
V1 Lapsed because of non-payment of the annual fee